1.13

3.42% -0.04

After Hours: 1.18 0.05 +4.42%

Telomir Pharmaceuticals Inc (TELO)

Overview News Price History Discussions Forecast

Telomir Pharmaceuticals Inc stock is traded at $1.13, with a volume of 35,285. It is down -3.42% in the last 24 hours and up +22.93% over the past month. Telomir Pharmaceuticals Inc is a preclinical-stage biotechnology company focused on the development of small-molecule therapeutics designed to address upstream biological drivers of aging and age-related diseases rather than treating symptoms alone. The company's research targets fundamental cellular processes associated with disease progression and functional decline, including metal-ion dysregulation, oxidative stress, epigenetic regulation, mitochondrial dysfunction, and telomere integrity. Telomir's investigational compound, Telomir-1 (Zn-Telomir), is a novel orally administered small molecule engineered to modulate intracellular metal balance particularly iron, copper, calcium, and zinc.

Previous Close:

$1.17

Open:

$1.18

24h Volume:

35,285

Relative Volume:

0.36

Market Cap:

$77.72M

Revenue:

Net Income/Loss:

$-9.22M

P/E Ratio:

-3.8738

EPS:

-0.2917

Net Cash Flow:

$-4.60M

1W Performance:

+7.62%

1M Performance:

+22.93%

6M Performance:

-0.88%

1Y Performance:

-22.07%

1-Day Range:

$1.11

$1.18

1-Week Range:

$1.0312

$1.20

52-Week Range:

$0.8885

$2.091

Telomir Pharmaceuticals Inc Stock (TELO) Company Profile

Name

Telomir Pharmaceuticals Inc

Sector

Healthcare (1077)

Industry

Biotechnology (602)

Phone

786-396-6723

Address

100 SE 2ND ST, MIAMI

Employee

Twitter

Next Earnings Date

2026-08-13

Latest SEC Filings

TELO's Discussions on Twitter

Compare TELO vs VRTX, REGN, ARGX, MRNA, RVMD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
TELO Telomir Pharmaceuticals Inc	1.13	80.47M	0	-9.22M	-4.60M	-0.2917
VRTX Vertex Pharmaceuticals Inc	540.26	139.93B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	826.64	86.57B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	1,038.12	64.62B	4.16B	1.29B	734.26M	19.58
MRNA Moderna Inc	133.32	69.62B	2.23B	-3.19B	-1.60B	-8.1462
RVMD Revolution Medicines Inc	211.74	46.01B	742.00K	-1.37B	-1.07B	-7.0731

Telomir Pharmaceuticals Inc Stock (TELO) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Feb-21-25	Initiated	Rodman & Renshaw	Buy

Telomir Pharmaceuticals Inc Stock (TELO) Latest News

Aug 14, 2026

Telomir Pharmaceuticals (TELO): John Paul DeJoria reports 5.169% ownership stake - Stock Titan

Aug 14, 2026

Telomir Flags Substantial Doubt About Ability to Continue as Going Concern - Minichart

Aug 14, 2026

Aug 13, 2026

Telomir Pharmaceuticals (NASDAQ:TELO) Releases Quarterly Earnings Results - MarketBeat

Aug 13, 2026

Telomir Pharmaceuticals | 10-Q: Q2 2026 Earnings Report - Moomoo

Aug 13, 2026

Aug 12, 2026

Telomir Pharmaceuticals (NASDAQ:TELO) Stock Price Down 3.4%Should You Sell? - MarketBeat

Aug 12, 2026

Aug 10, 2026

Telomir-Zn Preclinical Data Support Advancement in TNBC - TipRanks

Aug 10, 2026

Telomir Pharmaceuticals Announces Peer-Reviewed Publication of Preclinical Telomir-Zn Data Showing Tumor Suppression in Prostate and Triple-Negative Breast Cancer Models - Quiver Quantitative

Aug 10, 2026

Aug 04, 2026

Telomir Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Aminov Erez - Moomoo

Aug 04, 2026

Jul 31, 2026

Telomir Pharmaceuticals (TELO) Slides 3.4% to $1.21 as Key Support Level Comes into FocusFactor Rotation - Vinanet

Jul 31, 2026

Jul 30, 2026